Sekurova ON, Sun Y-Q, Zehl M, et al. Coupling of the engineered DNA "mutator" to a biosensor as a new paradigm for activation of silent biosynthetic gene clusters in Streptomyces. Nucleic acids research. 2021: gkab583.DNA replication fidelity in Streptomyces bacteria, prolific producers of many medically important secondary metabolites, is understudied, while in Escherichia coli it is controlled by DnaQ, the ϵ subunit of DNA polymerase III (DNA PolIII). Manipulation of dnaQ paralogues in Streptomyces lividans TK24, did not lead to increased spontaneous mutagenesis in this bacterium suggesting that S. lividans DNA PolIII uses an alternative exonuclease activity for proofreading. In Mycobacterium tuberculosis, such activity is attributed to t...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Organisms belonging to the Streptomyces genus produce a vast number of useful secondary metabolites,...
BACKGROUND: Recent advances in functional genomics, gene therapy, tissue engineering, drug discovery...
Streptomycete bacteria are a great source of natural bioactive secondary metabolites, some of which ...
Sun Y-Q, Busche T, Rückert C, et al. Development of a Biosensor Concept to Detect the Production of ...
Natural products produced by organisms are molecules that are structurally and functionally diverse...
New small-molecule drugs are needed, both to address existing disease and to combat the rise of anti...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Recombineering in bacteria is a powerful technique for genome reconstruction, but until now, it was ...
Recombineering in bacteria is a powerful technique for genome reconstruction, but until now, it was ...
Recombineering in bacteria is a powerful technique for genome reconstruction, but until now, it was ...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Recombineering in bacteria is a powerful technique for genome reconstruction, but until now, it was ...
Genome mining of actinomycete bacteria aims at the discovery of novel bioactive secondary metabolite...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Organisms belonging to the Streptomyces genus produce a vast number of useful secondary metabolites,...
BACKGROUND: Recent advances in functional genomics, gene therapy, tissue engineering, drug discovery...
Streptomycete bacteria are a great source of natural bioactive secondary metabolites, some of which ...
Sun Y-Q, Busche T, Rückert C, et al. Development of a Biosensor Concept to Detect the Production of ...
Natural products produced by organisms are molecules that are structurally and functionally diverse...
New small-molecule drugs are needed, both to address existing disease and to combat the rise of anti...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Recombineering in bacteria is a powerful technique for genome reconstruction, but until now, it was ...
Recombineering in bacteria is a powerful technique for genome reconstruction, but until now, it was ...
Recombineering in bacteria is a powerful technique for genome reconstruction, but until now, it was ...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Recombineering in bacteria is a powerful technique for genome reconstruction, but until now, it was ...
Genome mining of actinomycete bacteria aims at the discovery of novel bioactive secondary metabolite...
Actinomycete bacteria of the genus Streptomyces are major producers of bioactive compounds for the b...
Organisms belonging to the Streptomyces genus produce a vast number of useful secondary metabolites,...
BACKGROUND: Recent advances in functional genomics, gene therapy, tissue engineering, drug discovery...